Kala Bio (KALA) EPS (Diluted) (2020 - 2026)
Kala Bio (KALA) EPS (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.19 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.15 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | 4.21 |
| Sep 30, 2025 | -53.70 |
| Jun 30, 2025 | -85.64 |
| Mar 31, 2025 | -70.49 |
| Dec 31, 2024 | -107.68 |
| Sep 30, 2024 | -96.70 |
| Jun 30, 2024 | -158.06 |
| Mar 31, 2024 | -209.85 |
| Dec 31, 2023 | -177.36 |
| Sep 30, 2023 | -170.65 |
| Jun 30, 2023 | -218.05 |
| Mar 31, 2023 | -349.29 |
| Dec 31, 2022 | -422.30 |
| Sep 30, 2022 | 962.43 |
| Jun 30, 2022 | -953.85 |
| Mar 31, 2022 | -1,118.31 |
| Dec 31, 2021 | -1,823.86 |
| Sep 30, 2021 | -1,070.73 |
| Jun 30, 2021 | -1,413.45 |